wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33416440-119072B5-E602-4FB3-8A53-6C00736A7BA5
Q33416440-119072B5-E602-4FB3-8A53-6C00736A7BA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33416440-119072B5-E602-4FB3-8A53-6C00736A7BA5
Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours.
P2860
Q33416440-119072B5-E602-4FB3-8A53-6C00736A7BA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33416440-119072B5-E602-4FB3-8A53-6C00736A7BA5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b9b8a20633666d5cdb5b545bbd0467782edb2e45
P2860
Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study.